Understanding Drugs and Genetic Testing in Metastatic Prostate Cancer

This chapter explores the importance of comprehending drugs used in metastatic prostate cancer treatment and their side effects, particularly for board exams. It also highlights the significance of genetic testing for stage four prostate cancer patients, discussing common mutations and their treatment implications, including the potential use of PARP inhibitors.